Safety and Immunogenicity of CVD 1208S, a Live, Oral<i>ΔguaBA Δsen Δset Shigella flexneri</i>2a Vaccine Grown on Animal-Free Media
Karen L. Kotloff(University of Maryland, Baltimore), Myron M. Levine(University of Maryland, Baltimore), Stacey Wooden(Hospital for Tropical Diseases), Wendy L. Picking(Missouri College), Sofie Livio(University of Maryland, Baltimore), William C. Blackwelder(University of Maryland, Baltimore), Jakub K. Simon(University of Maryland, Baltimore), Marcela F. Pasetti(University of Maryland Global Campus), Marcelo B. Sztein(University of Maryland, Baltimore), James P. Nataro(University of Maryland, Baltimore), Eileen M. Barry(University of Maryland, Baltimore)
Cited by 93
Related Papers
Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: a systematic analysis for the Global Burden of Disease Study 2015
|The Lancet Infectious Diseases|2017|1.4k
Global burden of Shigella infections: implications for vaccine development and implementation of control strategies.
|PubMed|1999|1.3k
Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study
|The Lancet|2019|923